Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Genocea Biosciences (GNCA) - Total liabilities
Total liabilities on the balance sheet as of March 2022 : $26.4 M
According to Genocea Biosciences 's latest financial reports the company's total liabilities are $26.4 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Genocea Biosciences - Total liabilities on balance sheet (from 2012 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2021-12-31 | $28.89 M | -67.72% |
| 2020-12-31 | $89.51 M | 224.68% |
| 2019-12-31 | $27.56 M | 15.93% |
| 2018-12-31 | $23.78 M | 1.03% |
| 2017-12-31 | $23.53 M | -3.35% |
| 2016-12-31 | $24.35 M | 8.34% |
| 2015-12-31 | $22.48 M | 25.42% |
| 2014-12-31 | $17.92 M | 25.08% |
| 2013-12-31 | $14.33 M | 98.31% |
| 2012-12-31 | $7.22 M | 172.27% |
| 2011-12-31 | $2.65 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 519,587.16% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 261,385.44% | 🇺🇸 USA |
 Novavax NVAX | $2.51 B | 9,423.24% | 🇺🇸 USA |
 Agenus
AGEN | $0.46 B | 1,650.92% | 🇺🇸 USA |
 iBio IBIO | $24.82 M | -5.98% | 🇺🇸 USA |